Brief: Akebia Therapeutics Provides Update On Vafseo For Non-Dialysis Patients
28/10/2025 20:54
Oct 28 (Reuters) - Akebia Therapeutics Inc AKBA.O: AKEBIA THERAPEUTICS PROVIDES UPDATE ON VAFSEO FOR NON-DIALYSIS PATIENTS AKEBIA THERAPEUTICS INC - ANNOUNCES NO ALIGNMENT WITH FDA ON VALOR TRIAL DESIGN AKEBIA THERAPEUTICS INC - WILL NOT INITIATE VALOR TRIAL OR PURSUE BROAD LABEL Source text: ID:nGNXbnvY9y Further company coverage: AKBA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule